As of 2025-04-24, the Relative Valuation of Ikena Oncology Inc (IKNA) is (42.50) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.14 USD, the upside of Ikena Oncology Inc based on Relative Valuation is -3827.9%.
The range of the Relative Valuation is (35.81) - (48.28) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 29.3x - 43.9x | 36.6x |
| Forward P/E multiples | 26.3x - 39.5x | 32.9x |
| Fair Price | (35.81) - (48.28) | (42.50) |
| Upside | -3241.0% - -4335.3% | -3827.9% |
| Date | P/E |
| 2025-04-22 | -0.97 |
| 2025-04-21 | -0.93 |
| 2025-04-17 | -0.91 |
| 2025-04-16 | -0.91 |
| 2025-04-15 | -0.93 |
| 2025-04-14 | -0.96 |
| 2025-04-11 | -0.90 |
| 2025-04-10 | -0.87 |
| 2025-04-09 | -0.90 |
| 2025-04-08 | -0.88 |
| 2025-04-07 | -0.84 |
| 2025-04-04 | -0.92 |
| 2025-04-03 | -0.98 |
| 2025-04-02 | -1.02 |
| 2025-04-01 | -1.02 |
| 2025-03-31 | -1.05 |
| 2025-03-28 | -1.08 |
| 2025-03-27 | -1.09 |
| 2025-03-26 | -1.06 |
| 2025-03-25 | -1.10 |
| 2025-03-24 | -1.14 |
| 2025-03-21 | -1.12 |
| 2025-03-20 | -1.07 |
| 2025-03-19 | -1.06 |
| 2025-03-18 | -1.05 |
| 2025-03-17 | -1.07 |
| 2025-03-14 | -1.10 |
| 2025-03-13 | -1.11 |
| 2025-03-12 | -1.14 |
| 2025-03-11 | -1.13 |
| 2025-03-10 | -1.15 |
| 2025-03-07 | -1.18 |
| 2025-03-06 | -1.17 |
| 2025-03-05 | -1.10 |
| 2025-03-04 | -1.10 |
| 2025-03-03 | -1.05 |
| 2025-02-28 | -1.10 |
| 2025-02-27 | -1.12 |
| 2025-02-26 | -1.12 |
| 2025-02-25 | -1.14 |
| 2025-02-24 | -1.14 |
| 2025-02-21 | -1.14 |
| 2025-02-20 | -1.19 |
| 2025-02-19 | -1.19 |
| 2025-02-18 | -1.21 |
| 2025-02-14 | -1.22 |
| 2025-02-13 | -1.25 |
| 2025-02-12 | -1.19 |
| 2025-02-11 | -1.19 |
| 2025-02-10 | -1.19 |